Scarica l'app Stockscreener
76.97
1.45%
1.10
Dopo l'orario di chiusura:
69.98
-6.99
-9.08%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$75.87
Aprire:
$75.89
Volume 24 ore:
1.82M
Relative Volume:
0.99
Capitalizzazione di mercato:
$14.68B
Reddito:
$4.08B
Utile/perdita netta:
$32.48M
Rapporto P/E:
40.72
EPS:
1.89
Flusso di cassa netto:
$16.80M
1 W Prestazione:
-5.59%
1M Prestazione:
+15.94%
6M Prestazione:
+34.80%
1 anno Prestazione:
+41.83%
Intervallo 1D:
$75.42
$77.01
Intervallo di 1 settimana:
$73.25
$82.02
Portata 52W:
$50.35
$83.95
Incyte Corp Stock (INCY) Company Profile
Nome
Incyte Corp
Settore
Industria
Telefono
(302) 498-6700
Indirizzo
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE
Confronta INCY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| INCY | 76.97 | 14.68B | 4.08B | 32.48M | 16.80M | 1.89 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Incyte Corp Stock (INCY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-02-14 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2023-12-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2023-12-04 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2023-11-21 | Downgrade | Goldman | Buy → Neutral |
| 2023-07-25 | Iniziato | Citigroup | Buy |
| 2023-05-04 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-04-10 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-03-24 | Aggiornamento | SVB Securities | Underperform → Market Perform |
| 2023-01-31 | Iniziato | Piper Sandler | Overweight |
| 2022-08-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-08-03 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-07-28 | Iniziato | Wells Fargo | Equal Weight |
| 2022-02-09 | Downgrade | SVB Leerink | Mkt Perform → Underperform |
| 2022-01-18 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-07-20 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2021-02-10 | Downgrade | SVB Leerink | Mkt Perform → Underperform |
| 2021-01-07 | Iniziato | Truist | Buy |
| 2021-01-04 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-06-16 | Iniziato | The Benchmark Company | Hold |
| 2020-05-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-04-29 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-04-01 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-03-24 | Ripresa | William Blair | Outperform |
| 2020-03-13 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-02-04 | Ripresa | BofA/Merrill | Neutral |
| 2020-01-03 | Reiterato | BMO Capital Markets | Market Perform |
| 2020-01-03 | Downgrade | Mizuho | Buy → Neutral |
| 2020-01-02 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-10-03 | Iniziato | Mizuho | Buy |
| 2019-09-12 | Iniziato | BMO Capital Markets | Market Perform |
| 2019-09-05 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-09-05 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-09-05 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2019-05-21 | Iniziato | Credit Suisse | Neutral |
| 2019-05-03 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-04-11 | Iniziato | Stifel | Hold |
| 2019-04-03 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-01-24 | Aggiornamento | William Blair | Mkt Perform → Outperform |
Mostra tutto
Incyte Corp Borsa (INCY) Ultime notizie
Seizert Capital Partners LLC Has $6.24 Million Position in Incyte Co. (NASDAQ:INCY) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Sells 49,495 Shares of Incyte Co. (NASDAQ:INCY) - MarketBeat
Here’s How Jakafi’s Patent Expiry Impacts Incyte Corporation’s (INCY) Growth Prospects - Insider Monkey
Incyte Co. (NASDAQ:INCY) Shares Purchased by Mizuho Securities USA LLC - MarketBeat
Incyte Co. (NASDAQ:INCY) Shares Sold by Principal Financial Group Inc. - MarketBeat
Incyte Corp. stock outperforms competitors despite losses on the day - MarketWatch
KBC Group NV Reduces Position in Incyte Co. (NASDAQ:INCY) - MarketBeat
Incyte's SWOT analysis: stock faces patent cliff as pipeline progresses By Investing.com - Investing.com Australia
Incyte to Present at Upcoming Investor Conference - Yahoo Finance
INCY (Incyte) Cash Flow from Operations : $102 Mil (TTM As of Sep. 2024) - GuruFocus.com
Incyte's SWOT analysis: stock faces patent cliff as pipeline progresses - Investing.com
Anal Cancer Market Revenue to Expand Significantly by 2034, States DelveInsight Report | Incyte Corp, BioMimetix, Inovio Pharma, Merck Sharp & Dohme, Dustin Deming, Advaxis - The Globe and Mail
Anal Cancer Market Revenue to Expand Significantly by 2034, - openPR
State of New Jersey Common Pension Fund D Reduces Stock Holdings in Incyte Co. (NASDAQ:INCY) - MarketBeat
Incyte Co. (NASDAQ:INCY) Shares Sold by Amalgamated Bank - MarketBeat
Los Angeles Capital Management LLC Lowers Stock Holdings in Incyte Co. (NASDAQ:INCY) - MarketBeat
Chronic Hand Eczema Pipeline Update 2024: FDA Approvals, - openPR
Applied Finance Capital Management LLC Reduces Stock Holdings in Incyte Co. (NASDAQ:INCY) - MarketBeat
Incyte Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Barry P. Flannelly Sells 3,680 Shares of Incyte Co. (NASDAQ:INCY) Stock - MarketBeat
Incyte Insider Sold Shares Worth $293,210, According to a Recent SEC Filing - Marketscreener.com
Incyte Co. (NASDAQ:INCY) Stock Holdings Lowered by ARK Investment Management LLC - MarketBeat
Incyte Corp. stock outperforms competitors on strong trading day - MarketWatch
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Van ECK Associates Corp Has $8.79 Million Holdings in Incyte Co. (NASDAQ:INCY) - MarketBeat
Greenwood Capital Associates LLC Acquires Shares of 6,546 Incyte Co. (NASDAQ:INCY) - MarketBeat
Incyte Corporation: Will Their Focus on Oncological Innovations Pay Off?Major Drivers - Smartkarma
Incyte stock soars to 52-week high, hits $76.58 - Investing.com
Robeco Institutional Asset Management B.V. Buys 70,596 Shares of Incyte Co. (NASDAQ:INCY) - MarketBeat
NJ Judge Blocks Sun Pharma From Launching Hair Loss Drug - Law360
Incyte (NASDAQ:INCY) Sets New 52-Week HighWhat's Next? - MarketBeat
Incyte Corp (INCY)'s Winning Formula: Financial Metrics and Comp - GuruFocus.com
Incyte Co. (NASDAQ:INCY) Stock Holdings Trimmed by State of Alaska Department of Revenue - MarketBeat
Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday - MSN
Incyte (NASDAQ:INCY) Posts Quarterly Earnings Results, Misses Expectations By $0.12 EPS - MarketBeat
INCY Q3 Earnings Miss Estimates, Revenues Beat on Higher Product Sales - MSN
Incyte Corporation (NASDAQ:INCY) Q3 2024 Earnings Call Transcript - Insider Monkey
14,631 Shares in Incyte Co. (NASDAQ:INCY) Acquired by Integrated Advisors Network LLC - MarketBeat
Incyte Corp (INCY) Q3 2024 Earnings Call Highlights: Strong Reve - GuruFocus.com
Earnings call: Incyte reports robust growth and pipeline progress - Investing.com
Incyte's Jakafi Demand Is Strong, Analyst Upgrades Stock - Yahoo Finance
Incyte Raises Jakafi Sales Forecast, Surpassing Expectations - Finimize
Incyte (NASDAQ:INCY) Price Target Raised to $71.00 - MarketBeat
Incyte shares target upgraded, outperform rating on strong Q3 sales - Investing.com
Incyte stock target raised, underperform rating held on Jakafi revenue outlook - Investing.com
Incyte shares target raised, rating held on strong 3Q results - Investing.com
Incyte to Present at Upcoming Investor Conferences - Yahoo Finance
Incyte Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Incyte stock sees upside with strong Jakafi performance and robust pipeline—Citi - Investing.com
Incyte (INCY) PT Raised to $87 at Leerink Partners - StreetInsider.com
Incyte (INCY) PT Raised to $97 at Citi - StreetInsider.com
Incyte Corp Azioni (INCY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
7.22%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):